
AC Immune SA ACIU
€ 2.74
3.19%
Geschäftsbericht 2024
hinzugefügt 27.12.2025
AC Immune SA P/B 2011-2025 | ACIU
P/B Jährlich AC Immune SA
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 1.32 | 2.5 | 1.79 | 1.61 | 5.16 | 3.89 | - | - | - | - | - |
Alle Zahlen in CHF-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 5.16 | 1.32 | 2.71 |
P/B anderer Aktien in der Pharmaeinzelhändler
| Name | P/B | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
1.28 | - | 2.43 % | $ 254 M | ||
|
Aptevo Therapeutics
APVO
|
0.187 | $ 0.56 | -7.58 % | $ 155 K | ||
|
Aclaris Therapeutics
ACRS
|
0.979 | $ 3.03 | - | $ 234 M | ||
|
Alterity Therapeutics Limited
ATHE
|
125 | $ 3.19 | 0.63 % | $ 7.68 B | ||
|
Autolus Therapeutics plc
AUTL
|
0.991 | $ 1.82 | 8.68 % | $ 464 M | ||
|
Alpine Immune Sciences
ALPN
|
1.5 | - | - | $ 2.17 B | ||
|
Midatech Pharma plc
MTP
|
7.56 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 | - | - | $ 40.3 B | ||
|
Biophytis SA
BPTS
|
15.7 | - | -13.47 % | $ 169 M | ||
|
Aptorum Group Limited
APM
|
0.347 | $ 1.13 | -0.47 % | $ 6.16 M | ||
|
Aeglea BioTherapeutics
AGLE
|
1.4 | - | - | $ 1.01 B | ||
|
AIkido Pharma
AIKI
|
0.492 | - | 1.93 % | $ 17.4 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 | - | -1.52 % | $ 24.7 M | ||
|
AlloVir
ALVR
|
0.432 | - | 4.14 % | $ 49.1 M | ||
|
Ascendis Pharma A/S
ASND
|
8.34 | $ 210.42 | 0.69 % | $ 5 B | ||
|
Ampio Pharmaceuticals
AMPE
|
0.198 | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
0.364 | - | - | $ 10.1 M | ||
|
BioVie
BIVI
|
0.128 | $ 1.19 | -2.07 % | $ 1.76 M | ||
|
Avenue Therapeutics
ATXI
|
0.293 | - | -52.27 % | $ 4.45 M | ||
|
AVROBIO
AVRO
|
0.594 | - | 1083.1 % | $ 745 M | ||
|
BioDelivery Sciences International
BDSI
|
1.64 | - | -4.8 % | $ 255 M | ||
|
Athersys
ATHX
|
11.6 | - | 3.77 % | $ 22.4 M | ||
|
Институт стволовых клеток человека
ISKJ
|
6.81 | - | - | - | ||
|
ARCA biopharma
ABIO
|
1.27 | - | 1052.0 % | $ 415 M | ||
|
Bellicum Pharmaceuticals
BLCM
|
0.415 | - | -9.72 % | $ 5.89 M | ||
|
Acasti Pharma
ACST
|
0.612 | - | 4.01 % | $ 150 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
51.9 | - | -15.15 % | $ 60.3 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
32 | $ 0.19 | -13.09 % | $ 413 M | ||
|
Berkeley Lights
BLI
|
0.824 | - | -7.31 % | $ 87 M | ||
|
Albireo Pharma
ALBO
|
3.06 | - | -0.23 % | $ 916 M | ||
|
BioNTech SE
BNTX
|
5.29 | $ 94.4 | -0.13 % | $ 27.2 B | ||
|
Catalyst Biosciences
CBIO
|
0.428 | $ 12.31 | -0.32 % | $ 810 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 26.88 | -0.89 % | $ 1.3 B | ||
|
BeiGene, Ltd.
BGNE
|
75.9 | - | 0.49 % | $ 251 B | ||
|
Calithera Biosciences
CALA
|
19.6 | - | -10.95 % | $ 876 K | ||
|
Anika Therapeutics
ANIK
|
1.38 | $ 9.53 | -0.21 % | $ 140 M | ||
|
Certara
CERT
|
1.87 | $ 8.87 | -0.22 % | $ 1.42 B | ||
|
bluebird bio
BLUE
|
0.344 | - | - | $ 546 M | ||
|
Cellectis S.A.
CLLS
|
0.531 | $ 4.92 | 3.47 % | $ 116 M | ||
|
Arena Pharmaceuticals
ARNA
|
7.2 | - | -6.81 % | $ 3.04 B | ||
|
Acer Therapeutics
ACER
|
-0.724 | - | 2.71 % | $ 14 M | ||
|
Axon Enterprise
AXON
|
17.1 | $ 580.25 | -0.61 % | $ 44 B | ||
|
Ayala Pharmaceuticals
AYLA
|
0.994 | - | - | $ 7.46 M | ||
|
Aytu BioScience
AYTU
|
0.127 | $ 2.49 | 1.43 % | $ 15.6 M | ||
|
AstraZeneca PLC
AZN
|
2.07 | $ 92.65 | -0.27 % | $ 96.9 B | ||
|
ChromaDex Corporation
CDXC
|
9.34 | - | -0.88 % | $ 598 M | ||
|
Acorda Therapeutics
ACOR
|
0.154 | - | -24.86 % | $ 820 K | ||
|
Brickell Biotech
BBI
|
0.982 | - | -5.38 % | $ 6.06 M | ||
|
Burford Capital Limited
BUR
|
1.26 | $ 9.22 | 1.43 % | $ 1.49 B | ||
|
Celldex Therapeutics
CLDX
|
0.00176 | $ 26.01 | -1.5 % | $ 1.67 M |